X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (137) 137
humans (124) 124
cardiac & cardiovascular systems (81) 81
female (66) 66
male (66) 66
middle aged (64) 64
percutaneous coronary intervention (64) 64
aged (63) 63
harmonizing outcomes (63) 63
treatment outcome (57) 57
acute myocardial-infarction (47) 47
revascularization (45) 45
harmonizing current methodology (43) 43
mortality (36) 36
ami harmonizing outcomes (35) 35
bcr-abl transcripts (35) 35
stents (35) 35
risk factors (33) 33
time factors (33) 33
chronic myelogenous leukemia (32) 32
hematology (29) 29
drug-eluting stents (27) 27
prospective studies (27) 27
abridged index medicus (25) 25
adult (24) 24
clinical-outcomes (24) 24
impact (24) 24
transluminal angioplasty (24) 24
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (23) 23
oncology (23) 23
chronic myeloid-leukemia (22) 22
myocardial infarction - therapy (22) 22
percutaneous coronary intervention - adverse effects (22) 22
analysis (21) 21
bleeding (21) 21
leukemia, myelogenous, chronic, bcr-abl positive - genetics (21) 21
myocardial infarction - mortality (20) 20
cardiology (19) 19
imatinib (19) 19
imatinib mesylate (19) 19
myocardial infarction (19) 19
dermatology (18) 18
follow-up studies (18) 18
harmonizing outcome measures (18) 18
primary angioplasty (18) 18
young adult (18) 18
aged, 80 and over (17) 17
cardiac patients (17) 17
fusion proteins, bcr-abl - genetics (17) 17
percutaneous coronary intervention - methods (17) 17
prognosis (17) 17
bivalirudin (16) 16
clinical trials (16) 16
clopidogrel (16) 16
protein kinase inhibitors - therapeutic use (16) 16
acute catheterization (15) 15
cardiovascular (15) 15
coronary angiography (15) 15
follow-up (15) 15
intervention (15) 15
thrombosis (15) 15
anticoagulants (14) 14
atopic dermatitis (14) 14
benzamides (14) 14
care and treatment (14) 14
eczema (14) 14
heart attacks (14) 14
pyrimidines - therapeutic use (14) 14
stent (14) 14
unfractionated heparin (14) 14
adolescent (13) 13
antineoplastic agents - therapeutic use (13) 13
chronic myeloid leukemia (13) 13
drug therapy, combination (13) 13
electrocardiography (13) 13
platelet aggregation inhibitors - therapeutic use (13) 13
polymerase-chain-reaction (13) 13
severity of illness index (13) 13
tyrosine kinase inhibitors (13) 13
angioplasty (12) 12
anticoagulants - therapeutic use (12) 12
bare-metal stents (12) 12
drug therapy (12) 12
kaplan-meier estimate (12) 12
minimal residual disease (12) 12
patients (12) 12
piperazines - therapeutic use (12) 12
stent thrombosis (12) 12
antithrombins - therapeutic use (11) 11
coronary artery disease - therapy (11) 11
elevation myocardial-infarction (11) 11
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (11) 11
myocardial infarction - diagnosis (11) 11
optical coherence tomography (11) 11
patient outcomes (11) 11
peptide fragments - therapeutic use (11) 11
randomized-trial (11) 11
recombinant proteins - therapeutic use (11) 11
registries (11) 11
united states (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 01/2014, Volume 129, Issue 4, pp. 463 - 470
Journal Article
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2016, Volume 231, pp. 61 - 67
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 09/2016, Volume 88, Issue 3, pp. 369 - 377
Objectives: We report 2-year outcomes of the Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions (ORBIT II) trial, with... 
percutaneous coronary intervention | calcium | atherectomy | stents | Atherectomy | Percutaneous coronary intervention | Calcium | Stents | HARMONIZING OUTCOMES | CARDIAC & CARDIOVASCULAR SYSTEMS | ACUTE CATHETERIZATION | PACLITAXEL-ELUTING STENT | ACUTE MYOCARDIAL-INFARCTION | TREATING DE-NOVO | POOLED ANALYSIS | ROTATIONAL ATHERECTOMY | INTERVENTION | ARTERY-DISEASE | CLINICAL-OUTCOMES | Prospective Studies | Percutaneous Coronary Intervention - mortality | United States | Humans | Metals | Atherectomy, Coronary - instrumentation | Vascular Calcification - diagnostic imaging | Male | Prosthesis Design | Percutaneous Coronary Intervention - instrumentation | Time Factors | Vascular Calcification - mortality | Female | Myocardial Infarction - etiology | Atherectomy, Coronary - mortality | Coronary Stenosis - diagnostic imaging | Severity of Illness Index | Drug-Eluting Stents | Coronary Stenosis - therapy | Risk Factors | Kaplan-Meier Estimate | Atherectomy, Coronary - adverse effects | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Aged | Coronary Stenosis - mortality | Vascular Calcification - therapy | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Heart | Endarterectomy | Analysis | Stent (Surgery) | Index Medicus
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 116, Issue 6, pp. 845 - 852
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 10/2017, Volume 10, Issue 20, pp. 2017 - 2025
Objectives This study sought to compare clinical outcomes in a contemporary acute coronary syndrome (ACS) percutaneous coronary intervention (PCI) cohort... 
chronic kidney disease | percutaneous coronary intervention | long-term outcomes | acute coronary syndrome(s) | prasugrel or clopidogrel | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | RISK SCORE | ANTIPLATELET THERAPY | MALNUTRITION | AMI HARMONIZING OUTCOMES | IMPACT | PLATELET INHIBITION | LEVEL POOLED ANALYSIS | DRUG-ELUTING STENTS | Multivariate Analysis | Percutaneous Coronary Intervention - mortality | United States | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Acute Coronary Syndrome - physiopathology | Male | Renal Insufficiency, Chronic - complications | Acute Coronary Syndrome - complications | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Renal Insufficiency, Chronic - mortality | Ticlopidine - administration & dosage | Prasugrel Hydrochloride - administration & dosage | Myocardial Infarction - etiology | Kidney - physiopathology | Databases, Factual | Platelet Aggregation Inhibitors - adverse effects | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Prasugrel Hydrochloride - adverse effects | Chi-Square Distribution | Renal Insufficiency, Chronic - physiopathology | Ticlopidine - analogs & derivatives | Propensity Score | Stroke - etiology | Acute Coronary Syndrome - therapy | Clopidogrel | Aged | Coronary Thrombosis - etiology | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Index Medicus
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 02/2016, Volume 9, Issue 4, pp. 331 - 337
Journal Article
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 12/2012, Volume 5, Issue 6, pp. 805 - 812
Background-Data from randomized trials has demonstrated the superiority of bivalirudin to glycoprotein IIb/IIIa inhibitors plus heparin in patients undergoing... 
Bivalirudin | Primary PCI | Complications | Bleeding | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | bivalirudin | bleeding | complications | STENT THROMBOSIS | primary PCI | TRIAL | AMI HARMONIZING OUTCOMES | BLOOD-TRANSFUSION | BLEEDING AVOIDANCE STRATEGIES | ELEVATION MYOCARDIAL-INFARCTION | CLINICAL-OUTCOMES | UNFRACTIONATED HEPARIN | Recombinant Proteins - therapeutic use | Recurrence | Myocardial Infarction - mortality | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Heparin - therapeutic use | Male | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Time Factors | Fibrinolytic Agents - therapeutic use | Female | Registries | Thrombosis - prevention & control | Drug Therapy, Combination | Odds Ratio | Platelet Aggregation Inhibitors - therapeutic use | Stroke - prevention & control | Hospital Mortality | Antithrombins - therapeutic use | Risk Factors | Hospitals, University | Anticoagulants - therapeutic use | Logistic Models | Treatment Outcome | Chi-Square Distribution | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Propensity Score | Stroke - etiology | Thrombosis - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Aged | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Hemorrhage - chemically induced | Ontario | Percutaneous Coronary Intervention - adverse effects | Index Medicus
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2013, Volume 112, Issue 6, pp. 753 - 760
Journal Article
Journal Article